XBP1 and metabolic dysfunction-associated steatotic liver disease: To further understand the mechanism of FT@XBP1 on FFC-induced NAFLD progression, we examined the plasma endotoxin levels and found that plasma LPS levels were significantly elevated in the FFC dietary group compared with the CD group, whereas FT@XBP1 treatment obviously reversed this effect (Figure 6C).